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       MDMA generally known as ecstasy, have deleterious effects on the serotonergic neurotransmitter 
system. Recent findings suggest that the liver and brain are major target organs of MDMA-related toxicities. 
Although most research is being dynamically performed on brain, however, the molecular mechanisms by 
which MDMA elicits adverse effects in both organs are poorly undrestood.The present study was performed 
to obtain evidence for molecular mechanism of apoptosis involved in MDMA-induced hepatotoxicity in rat 
liver after MDMAadministration. Moreover, the antagonistic effect of pentoxifylline was assessed on 
hepatotoxicity after MDMA administration. In this experimental study, sample size and power in each group 
were calculated as 10 rats with 95% confidence level and 5% confidence interval. In the study, four 
experimental groups were selected including Control Normal, MDMA, MDMA+PTX and PTX+MDMA. 
MDMA was dissolved in PBS and intraperitoneally injected three doses of 7.5mg/kg with two hours gap 
between doses. Pentoxyfilline also was injected as 100mg/kg, simultaneously with third dose of MDMA. 
After treatment, total RNA was isolated from liver tissue (5mg). Absorbance at 260nm, 280nm and 230nm 
were measured and immediately reverse transcription was performed. Included target genes were BAD and 
BCL-XL as pro-apoptotic and anti-apoptotic gene, respectively. After set up and validation, Real-Time PCR 
were performed and obtaining data were statistically analyzed to determine significantly differences between 
groups. Using Real-Time quantitative PCR results, BCL-XL gene expression ratio significantly increased in 
MDMA+PTX group. Moreover, BAD gene expression ratio increased and up-regulated in PTX+MDMA 
group (P-value <0.001).Our study focused on molecular mechanism of MDMA in programmed cell death 
using gene expression quantification of a pro-apoptotic and anti-apoptoic gene in MDMA-induced 
hepatotoxocity. The results shown MDMA prompted apoptosis in liver and pentoxifylline protects 
hepatotoxicity after and befor taking MDMA. 
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INTRODUCTION 
    Methylenedioxymethampetamine (MDMA) 
generally known as ecstasy, is an illicit drug used 
by individuals seeking mood enhancement [1]. 
neuroimaging researches have investigated the 
structural, chemical and functional differences of 
MDMA on the human brain and other organs. The 
effects of Ecstasy vary from almost universal 
minor symptoms to those that are rare but 
potentially life-threatening [2]. Increasing 
evidence suggests that one way of MDMA-
induced toxicity involves abrupt death, 
rhabdomyolysis, hyperpyrexia and multi-organ 
failure, isolated liver failure, the serotonin 
syndrome, an acute panic disorder and 
hyponatraemia with cerebral oedema. The effects 
 




of MDMA differ according to the dose, frequency 
and consumption period [3]. Researches and 
studies on MDMAin animals has been shown to 
have deleterious effects on the serotonergic 
neurotransmitter system [4]. Recent findings, 
moreover, suggest that the liver and brain are 
major target organs of MDMA-related toxicities 
[5]. Although most research is being dynamically 
performed on brain, however, the molecular 
mechanisms by which MDMA elicits adverse 
effects in both organs are poorly understood. 
Apoptotic cell death is a genetically programmed 
mechanism(s) that allows the cell to commit 
suicide [6]. Methamphetamine and other 
amphetamine derivatives trigger the programmed 
cell death pathway by activation of pro-apoptotic 
and inhibition of anti-apoptotic genes [7]. The B-
cell lymphoma-2 (Bcl-2) family is a group 
comprising bcl2, Bcl-xL, Bcl-w and Mcl-1 (anti-
apoptotic), bax, Bak, Bok, Bid, Bad, Bik, Bmf, 
Hrk, Noxa and Puma (pro-apoptotic) genes  which 
directly involved in regulating apoptosis.  
Pentoxifylline (PTX), a non-
specific phosphodiesterase inhibitor, is one of the 
main pharmacological treatment options for the 
treatment of severe alcoholic hepatitis [8] and 
routinely employed for circulatory diseases for 
>20 years. PTX is a ligand of adenosine receptors, 
a modulator of the ryanodine Ca
2+
-release channel 
of the sarco(endo)plasmic reticulum, down-
regulator of tumor necrosis factor-alpha (TNF-α) 
and the transcription factorNF-κB[9]. 
The present study was performed to obtain 
evidence for molecular mechanism of apoptosis 
involved in MDMA-induced hepatotoxicity in rat 
liver after MDMAadministration. Moreover, the 
antagonistic effect of pentoxifylline was assessed 
on hepatotoxicity after MDMA administration.  
 
MATERIALS AND METHODS 
Animal drug administration 
In this experimental study, sample size and power 
in each group were calculated as 10 rats with 95% 
confidence level and 5% confidence interval. All 
procedures were performed in accordance with 
Ethics Committee of Iran University of Medical 
Sciences and confirmed to European 
Communities Council Directive of November 
1986 (86/609/EEC). All chemicals were 
purchased from Sigma except pentoxifylline 
powder that was gifted kindly by the Amin 
Pharmaceutical Co (Esfahan-Iran) and pure 
MDMA was gifted by Dr. Foroumadi, Faculty of 
Pharmacy and Pharmaceutical Sciences Research 
Center, Tehran University of Medical Sciences. 
Adult male Wistar rats, in the study, were selected 
as weighting 250–300g (Cellular and molecular 
research center, Iran university of Medical 
Sciences, Tehran, Iran). The animals were housed 
under reversed 12:12 hours light and dark cycles 
at room temperature (22±2°C). In the study, four 
experimental groups (10 rats/group) were selected 
including Control Normal, MDMA, 
MDMA+PTX (MDMA followed by PTX) and 
PTX+MDMA (PTX followed by MDMA). 
MDMA was dissolved in Phosphate Buffer Saline 
(PBS) and intraperitoneally (IP) injected three 
doses of 7.5mg/kg with two hours gap between 
doses. In MDMA+PTX group, Pentoxyfilline was 
injected as 100mg/kg, simoultanously with third 
dose of MDMA. Furthermore, MDMA was 
received one week after pentoxyfilline in 
PTX+MDMA group. 
Two weeks after first drug administration, 
animals were anaesthetized by Ketanamine and 
xylazine before being put into death. The liver 
tissue rapidly was removed, dissected and 
molecular procedures immediately performed. 
Molecular procedures 
Total RNA was isolated from liver tissue (5mg) 
through High Pure RNA isolation kit (Roche, 
Germany). According to the handbook kit, the 
samples were prepared using tissue lysis buffer. 
All samples, furthermore, were treated with 
DNase I enzyme (supported in the kit) to avoid 
DNA contamination. Finally, absorbance at 
260nm (to calculate concentration), 280nm and 
230nm (to determine purification) were measured 
using Nanophotometer 2000c (Thermo Science, 
USA). Immediately, Reverse transcription (RT) 
reaction was performed using RevertAid First 
Strand cDNA Synthesis Kit (Thermo Scientific, 
Lithuania). 
Primer design 
Included target genes, in this experimental study, 
were BAD and BCL-XL as pro-apoptotic and anti-
 




apoptotic gene, respectively. In according to 
relative quantification analysis, Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) gene was 
selected as internal reference gene. 
The sequences of interest genes were obtained 
from NCBI database and primer sets were 
designed using PrimerExpress v.3.0 (Applied 
Biosystems, Foster City, USA) and GeneRunner 
software.  All designed oligonucleotids were 
analyzed in Basic Local Alignment Search Tool 
to avoid secondary structure and homology with 
other region of genome. Primer sequences are 
shown in Table 1.   
 
Table 1. primer sequences, length, Tm and amplicons. 
Oligo name Sequence (5′→3′)   Tm                    
gapdh-F  AAGTTCAACGGCACAGTCAAGG57.8                     
gapdh-R   CATACTCAGCACCAGCATCACC  56.7 
bad-F      GGAGCATCGTTCAGCAGCAG         58 
bad-R       CCATCCCTTCATCTTCCTCAGTC  57.6 
Bcl-xl-F     GCTGGTGGTTGACTTTCTCTCC     56.4 
bcl-xl-R     GGCTTCAGTCCTGTTCTCTTCG 56.7 
 
Relative quantification analysis 
In the assay, fluorescent dye and Real-Time PCR 
instrument were SYBR Green I and Rotor-Gene 
Q apparatus (Qiagen, Germeny), respectively. 
Total PCR reaction volume was 25μl including 
12.5μl of SYBR Green I PCR Master Mix 
(TaKaRa, Japan), forward and reverse 
oligonucleotide (400nM), 5μl of cDNA template 
(60ng/μl) and ddH2O (5.5μl). Thermal cycling 
programme was performed including 30sec at 
95°C, following 5sec at 95°C and 25sec at 60°C 
for 40 cycles and melting curve analysis carried 
out from 65°C to 95°C, rising 1°C each step. 
Melting curve analysis was used to confirm the 
specific amplification of fragments and no primer 
dimmers formation. Real-Time PCR reactions for 
each sample were performed in triplicate to 
confirm accuracy, reproducibility and intra-assay 
precision. Amplification efficiency for target and 
reference genes was validated using 10-fold 
dilution series of control cDNA template as 2000, 
200, 20, 2ng. Then, standard curves were drawn 
using plotting the logarithmic input cDNA 
concentration versus mean CT and the slope was 
determined. PCR reaction efficiency was 
calculated via formula; E= (10 
-1/slope
). Expression 
levels of target genes were calculated using 
comparative threshold cycle formula. The relative 
expression ratio (R) of target genes were 
calculated based on efficiency (E) and cross point 
deviation (CP) of unknown samples versus 
controls using formula;  
Ratio=  
Data processing and statistical analysis 
All mathematical procedures were calculated 
using Statistical Package for the Social Sciences 
software (SPSS Inc v. 22). The statistical 
operations were included Mean ratio (M), 
Standard Deviation (SD), Determination 
coefficient (R
2
), Confidence Intervals (95% CI) 
and Standard Error of Mean (SEM). One-way 
ANOVA, non-parametric (independent sample 
Kruskal-Wallis test) and Tukey analysis (Post hoc 
test) were performed to determine significantly 
differences between gene expression of interest 




   The slope of standard curves for BCL-XL, BAD 
and GAPDH genes were obtained -3.46, -3.31 and 
-3.39, respectively (Figure 1).  
 
 
Figure 1. Standard curves: Mean threshold cycle versus log 
cDNA concentration. Y-intercept and Determination 
coefficient for interest genes; bad (y = -3.310x + 35.285 and 
R² = 1.00), bcl-xl 
 




(y = -3.460x + 29.482 and R² = 1.00) and gapdh (y = -3.393x 
+ 28.238 and R² = 1.00). 
PCR efficiency (E), therefore, for target and 
reference genes were calculated 1.94 (BCL-XL), 2.00 
(BAD) and 1.97 (GAPDH). Melting curve analysis 
shown the specific amplicon for BCL-XL, BAD and 
GAPDH melted at 82.5ºC, 89.0ºC and 85.5ºC, 
respectively (Figure 2). The results of melting 
curves were confirmed by gel electrophoresis of 
PCR product.  To determine whether the gene 
expression of pro-apoptotic and anti-apoptotic 
changed in rat liver after MDMAexposure, the level 
of mRNA for BCL-XL and BAD were measured.  
 
 
Figure 2. Melting curve analysis: derevative fluorescent 
versus temperature.a: gapdh (85.5ºC), b: bcl-xl (82.5ºC), c: 
bad (89.0ºC). 
 
The gene expression ratio of BCL-XL increased in 
MDMA+PTX group compared to MDMA and 
PTX+MDMA groups (Table 2, Figure 3-A). The 
statistical analysis shown significant difference 
for BCL-XL expression between experimental 
groups (P-
value<
0.001). BAD gene expression ratio, furthermore, 
increased approximately 5-fold in PTX-MDMA 
group compared to other groups (Table 2, Figure 
3-B) in statistical analysis, outlier data were 








Table 2.Quantitative results of BCL-XL and BAD gene 
expression ratio in excremental groups 



















19.75 10.61 11.06 <0.001 
The ratio of pro-apoptotic to anti-apoptotic gene 
(BAD/BCL-XL) for experimental groups were 
calculated as 19.75 (MDMA), 10.61 



































Figure 3.Gene expression (Median±IQR) and pro-apoptotic 




    Although MDMA alone or in combination 
with other abused substances can damage 
various organs (such as liver, heart, brain, and 
kidney), recent epidemiological study are 
shown that MDMA abuse has increased almost 
in all parts of the world. Most research is being 
dynamically performed to undrestand the 
mechanism of MDMA-mediated neurotoxicity 
[10-12] and hepatotoxicity [13]. recent studies 
have shown that co-administration of MDMA 
with ethanol significantly enhances 
neurotoxicity and hepatotoxicity [14]. Although 
many investigations have reported MDMA-
induced liver damage [13, 15, 16], the 
fundamental mechanism accounting for hepatic 
toxicity is poorly understood. 
The present study focused on molecular 
mechanism of MDMA in apoptosis using gene 
expression quantification of a pro-apoptotic and 
an anti-apoptotic gene in hepatotoxocity. Our 
findings shown that BCL-XL gene expression 
increased in MDMA+PTX group compared to 
MDMA and PTX+MDMA groups. BCL-XL is an 
anti-apoptotic gene that its expression up-
regulated after PTX administration.  
This result may confirmed the role of PTX as an 
anti-apoptotic-inducer. BAD, the another target, 
is a pro-apoptic gene that its expression up-
regulated in MDMA group, and decreased in 
MDMA+PTX and PTX+MDMA groups, 
respectively. This pattern could be shown the 
effect of MDMA triggering pro-apoptotic gene 
expression and the antagonistic effect of 
pentoxifylline on hepatotoxicity before and 
after MDMA administration. According to the 
data, furthermore, the ratio of pro-apoptotic to 
anti-apoptotic gene (BAD/BCL-XL) revealed this 
ratio increased in MDMA group compared to 
other excremental groups (Table 2, Figure 3-C).  
This result confirmed that MDMA activated 
pro-apoptotic gene expression and induced 
apoptosis. 
Upreti and his team assessed on the levels of 
Bcl-2 and phospho-Bcl-2 (or Bcl-XL) protein in 
cytosol and mitochondria  [5]. They were 
reported that anti-apoptotic Bcl-2 was 
phosphorylated (inactivated), although its 
protein level was unchanged in MDMA-
exposed tissues. In addition, the level of Bcl-
XL, another member of the anti-apoptotic Bcl-2 
family, was decreased in the cytoplasm, 
however, this protein  increased in the 
mitochondria, suggesting its translocation after 
MDMA exposure. 
Histopathological examination revealed that 
treatment with PTX significantly suppressed 
early inflammation and the apoptosis of 
hepatocytes induced by ConA [17]. Moreover, 
some reports suggest  
that PTX administration might increase the 
effectiveness of antitumor chemotherapy [18]. 
Pentoxifylline effects depends on its dose and  
time duration. Ji Q and colleagues reported that 
single dose of PTX dramatically reduced brain 
inflammation and apoptosis for up to 16 h post-
injury [19].  
Hernandez-Flores and his coleagues 
investigated on cytotoxic effect of PTX and CIS 
either alone or in combination on HeLa, SiHa 
and HaCaT cells [9]. They reported that PTX is 
able to markedly down-regulate the expression 
of Bcl-2 and BCL-XL proteins in both HeLa and 
SiHa cells as compared with untreated cells. 
In some types of cancers pentoxifylline 
sensitizes these cells to the toxic action of 
chemotherapeutics drugs such as adriamycin 
and inducing apoptosis. Recent investigation 
have shown that PTX is toxic for cancer cells 
affecting cell viability and inducing apoptosis. 















the cell cycle in which the tumors are more 
sensitive to the toxic effects of some 
chemotherapeutic and radiotherapeutic agents. 
In the parallel analysis, Movassaghi et al. 
performed chromosome staining in Rat liver to 
investigating of apoptotic bodies using TUNEL 
(Terminal deoxynuclotidyl transfrased UTP 
nickend labeling) assay [20]. They shown that 
the number of TUNEL-positive cells in rat liver 
was significantly decreased in MDMA followed 
PTX group compared to MDMA and vehicle 
groups. In addition, they published the 
apoptotic bodies were significantly decreased 
by PTX in the liver and there was no significant 
difference between the number of apoptotic 
bodies in MDMA followed PTX group and 
control groups. 
Our study focused on molecular mechanism of 
MDMA in programmed cell death using gene 
expression quantification of a pro-apoptotic and 
anti-apoptoic gene in MDMA-induced 
hepatotoxocity. The results shown MDMA 
prompted apoptosis in liver and pentoxifylline 
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